ALNY
ALNYLAM PHARMACEUTICALS, INC.
ALNYLAM PHARMACEUTICALS, INC. (ALNY) has 1 SEC Form 4 filing (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 3, 2026.
Insiders have net sold $1.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Yvonne L. Greenstreet
- Employees:2,500
- HQ:Cambridge, MA, US
- IPO:2004-06-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$36.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
PYOTT DAVID E IFirst filing | Director | Sale | 3,830 | $1.1M | Jun 3 | SEC ↗ |
Related companies
ALNYLAM PHARMACEUTICALS, INC. is in the Healthcare sector.